Trial Profile
Randomized Comparison Between a DES and a BMS to Assess Neointimal Coverage by OCT Evaluation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms DEMONSTRATE
- 13 Mar 2012 New trial record